Investor · Cambridge, MA

Jeffrey Albers

Open Jeffrey in the network graph →

Filings

3

SEC Form D

Connections

44

co-filers

Capital

$208.0M

across filings

Active

Apr 2018

to May 2025

Most-connected co-filers (44)

Keith Flaherty · Pembroke, MA2 shared Brian Piper · Boston, MA2 shared Andrew Fedder · Boston, MA2 shared Jean-Francois Formela · Cambridge, MA2 shared Keith Flaherty · Cambridge, MA2 shared Shelley Chu · San Diego, CA2 shared Erik Mulloy · Edmond, OK1 shared Erik S. Bertsen · London, United Kingdom1 shared Joseph S. Hardiman · London, United Kingdom1 shared Stable Seed Management, Ltd · London, United Kingdom1 shared William J. Forrest · Poway, CA1 shared Gwenne Henricks · Poway, CA1 shared Robert Fishman · Poway, CA1 shared Brian Grassadonia · San Francisco, CA1 shared Daniele Perito · San Francisco, CA1 shared Marcelo Cortes · San Francisco, CA1 shared Peter J. Heaps · Grand Cayman, Cayman Islands1 shared Akihiro C. Ko · Baltimore, MD1 shared Hiroaki C. Kobayashi · Baltimore, MD1 shared Alexis Borisy · Cambridge, MA1 shared Adam Friedman · Boston, MA1 shared Jeffrey Cleland · BALTIMORE, MD1 shared Amy G. Ronneberg · Fort Worth, TX1 shared Menelas N. Pangalos · Boston, MA1 shared

Recent filings (3)

Antares Therapeutics, Inc.May 2025 · 18 co-filers$136.7M Antares Therapeutics, Inc.May 2025 · 18 co-filers$136.7M Scorpion Therapeutics, Inc.Jul 2024 · 29 co-filers$150.0M Scorpion Therapeutics, Inc.Jul 2024 · 29 co-filers$150.0M Magenta Therapeutics, Inc.Apr 2018 · 28 co-filers$52.3M Magenta Therapeutics, Inc.Apr 2018 · 28 co-filers$52.3M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Jeffrey in the interactive graph →